Search results :

Rosiglitazone

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A10BG02

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Anaemia Anaemia common, 7.1% x x x x x x x x x
Nasopharyngitis Nasopharyngitis 6.3% - 6.9% x x x
Upper respiratory tract infection Upper respiratory tract infection 4.3% - 9.9% 8.7% x x x
Hypertension Hypertension 4.4% - 6.1% x x x x
Headache Headache 5.4% - 20% 5% x x x x x x x x x
Thrombocytopenia Thrombocytopenia common x
Back pain Back pain 4% - 9% 3.8% x x x x x x x x
Arthralgia Arthralgia 4.2% - 5% x x x
Musculoskeletal discomfort Arthralgia 4.2% - 5% x x x
Myalgia x
Hyperglycaemia Hyperglycaemia 3.9% - 10% 5.7% x x x x x x x x
Asthenia Fatigue 1.9% - 9% 5% x x x x x x x x
Fatigue Fatigue 1.9% - 9% 5% x x x x x x x x
Sinusitis Sinusitis 3% - 12% 4.5% x x x x x x x x
Diarrhoea Diarrhoea 2.3% - 35% 3.3% x x x x x x x x
Hypoglycaemia Hypoglycaemia 1% - 13% 0.2% x x x x x x x x x
Anaphylactic shock Anaphylactic shock very rare, postmarketing x x x x x
Angioedema Angioedema very rare, postmarketing x x x x x x
Dermatitis Rash very rare, postmarketing x x x x x
Rash Rash very rare, postmarketing x x x x x
Cardiac failure congestive Cardiac failure congestive postmarketing, rare x x x x x x x x
Hepatitis Hepatitis postmarketing x x x x x x x
Pleural effusion Pleural effusion postmarketing x x x x x x x
Pruritus Pruritus very rare, postmarketing x x x x x
Pulmonary oedema Pulmonary oedema postmarketing, rare x x x x x x x x
Erythema multiforme Stevens-Johnson syndrome postmarketing x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x
Urticaria Urticaria very rare, postmarketing x x x x x x
Hepatic failure Hepatic failure postmarketing x x x x x x x x
Hepatic function abnormal Hepatic function abnormal rare x
Visual acuity reduced Visual acuity reduced postmarketing x x x x
Macular oedema Macular oedema postmarketing, rare x x x x x
Diabetes mellitus Worsening of diabetes postmarketing x x x
Diabetes mellitus x
Weight increased Weight increased very rare x x x
Infection Infection x x x x x
Connective tissue disorder Connective tissue disorder x
Constipation Constipation x x
Dizziness Dizziness x
Oedema Oedema x x x x x x x x x
Eye disorder Eye disorder x
Multiple fractures Fracture x x x x x
Fracture Fracture x x x x x
Gastrointestinal disorder Gastrointestinal disorder x
Cardiac disorder Cardiac disorder x
Cardiac failure Cardiac failure x x x x x x
Hyperbilirubinaemia Hyperbilirubinaemia x x x x x x x x
Hypercholesterolaemia Hypercholesterolaemia x
Hyperlipidaemia Hyperlipidaemia x
Hypertriglyceridaemia Hypertriglyceridaemia x
Blood triglycerides increased Hypertriglyceridaemia x
Immune system disorder Immune system disorder x
Ischaemia Ischaemia x
Leukopenia Leukopenia x
Myocardial infarction Myocardial infarction x x
Acute coronary syndrome Myocardial infarction x x
Nausea Nausea x x x
Nervous system disorder Nervous system disorder x
Ligament sprain Sprain x
Cerebrovascular accident Cerebrovascular accident x
Oedema peripheral Oedema peripheral x
Myocardial ischaemia Myocardial ischaemia x x
Ketonuria Ketonuria x x x
Malnutrition Malnutrition x
Myalgia Myalgia x
Volume blood increased Volume plasma increased x x x x x x x x
Increased appetite Increased appetite x x
Hepatic enzyme increased Hepatic enzyme increased x
Hepatobiliary disease Hepatobiliary disease x
Fluid retention Fluid retention x
Parotid gland enlargement Parotid gland enlargement x
Anion gap increased Anion gap increased x x x
Haematocrit decreased Haematocrit decreased x
Blood cholesterol increased High cholesterol x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

rosiglitazone / rosiglitazone

Side effects:38
Source:EMA

ROSIGLITAZONE MALEATE / AVANDIA

Side effects:13
Source:FDA

rosiglitazone maleate / Avandia

Side effects:18
Source:FDA

ROSIGLITAZONE MALEATE / AVANDIA

Side effects:18
Source:FDA

ROSIGLITAZONE MALEATE / AVANDIA

Side effects:20
Source:FDA

ROSIGLITAZONE

Side effects:34
Source:FDA Structured Product Label

ROSIGLITAZONE

Side effects:34
Source:FDA Structured Product Label

ROSIGLITAZONE

Side effects:39
Source:FDA Structured Product Label

ROSIGLITAZONE (ROSIGLITAZONE MALEATE) / AVANDIA 8MG

Side effects:40
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label